Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 1,732.00
-56.00 (-3.13%)
Oct 17, 2025, 3:30 PM JST
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of 688.11 billion as of October 17, 2025. Its market cap has increased by 188.19% in one year.
Market Cap
688.11B
Enterprise Value
976.90B
Revenue
416.16B
Ranking
n/a
PE Ratio
36.40
Stock Price
1,732.00
Market Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 688.11B, an increase of 234.15%. That is a compound annual growth rate of 3.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 688.11B | 207.64% |
| Dec 30, 2024 | 223.67B | 20.82% |
| Dec 29, 2023 | 185.14B | -53.35% |
| Dec 30, 2022 | 396.90B | -24.60% |
| Dec 30, 2021 | 526.41B | -13.00% |
| Dec 30, 2020 | 605.08B | -28.50% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.59T |
| Daiichi Sankyo Company | 7,572.20B |
| HOYA Corporation | 7,530.85B |
| Takeda Pharmaceutical Company | 6,577.56B |
| Otsuka Holdings | 4,318.00B |
| Terumo | 3,676.57B |
| Astellas Pharma | 2,886.87B |
| Shionogi & | 2,055.98B |